Boissel Stephane 4
4 · SANGAMO THERAPEUTICS, INC · Filed Feb 27, 2019
Insider Transaction Report
Form 4
Boissel Stephane
EVP, Corporate Strategy
Transactions
- Award
Stock Option (Right-to-Buy)
2019-02-25+105,000→ 105,000 totalExercise: $9.03Exp: 2029-02-24→ Common Stock (105,000 underlying) - Award
Common Stock
2019-02-25+17,500→ 17,500 total
Footnotes (2)
- [F1]Represents 17,500 shares subject to restricted stock units granted on February 25, 2019 that will vest in three (3) equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer through such date.
- [F2]One-quarter (1/4) of the option shares vest and become exercisable upon completion of one (1) year of service by the Reporting Person measured from the February 25, 2019 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date.